Insider Trading Alert - OMI, PSX And HCA Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, May 8, 2014, 131 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $460.00 to $19,915,560.00.

Highlighted Stocks Traded by Insiders:

Owens & Minor (OMI) - FREE Research Report

Meier Richard A, who is EVP, Chief Financial Officer at Owens & Minor, bought 2,500 shares at $32.50 on May 8, 2014. Following this transaction, the EVP, Chief Financial Officer owned 40,566 shares meaning that the stake was reduced by 6.57% with the 2,500-share transaction.

The shares most recently traded at $33.03, up $0.53, or 1.6% since the insider transaction. Historical insider transactions for Owens & Minor go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 2,545
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 2,545
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 45,785

The average volume for Owens & Minor has been 506,200 shares per day over the past 30 days. Owens & Minor has a market cap of $2.0 billion and is part of the services sector and wholesale industry. Shares are down 10.86% year-to-date as of the close of trading on Thursday.

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare logistics company. The company offers supply chain assistance to the providers of healthcare services; and the manufacturers of healthcare products, supplies, and devices. The stock currently has a dividend yield of 3.09%. The company has a P/E ratio of 18.4. Currently, there are no analysts who rate Owens & Minor a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OMI - FREE

TheStreet Quant Ratings rates Owens & Minor as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Owens & Minor Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Phillips 66 (PSX) - FREE Research Report

Tilton Glenn F, who is Director at Phillips 66, bought 5,900 shares at $84.41 on May 8, 2014. Following this transaction, the Director owned 5,900 shares meaning that the stake was reduced by 100% with the 5,900-share transaction.

Lowe John E, who is Director at Phillips 66, sold 5,000 shares at $84.55 on May 8, 2014. Following this transaction, the Director owned 35,000 shares meaning that the stake was reduced by 12.5% with the 5,000-share transaction.

Loomis William R Jr, who is Director at Phillips 66, bought 5,907 shares at $84.57 on May 8, 2014. Following this transaction, the Director owned 27,267 shares meaning that the stake was reduced by 27.65% with the 5,907-share transaction.

The shares most recently traded at $81.48, down $3.09, or 3.79% since the insider transaction. Historical insider transactions for Phillips 66 go as follows:

  • 4-Week # shares bought: 13,600
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 13,600
  • 12-Week # shares sold: 5,000
  • 24-Week # shares bought: 13,600
  • 24-Week # shares sold: 5,000

The average volume for Phillips 66 has been 3.2 million shares per day over the past 30 days. Phillips 66 has a market cap of $48.1 billion and is part of the basic materials sector and energy industry. Shares are up 7.51% year-to-date as of the close of trading on Thursday.

Phillips 66 operates as an energy manufacturing and logistics company. It operates in four segments: Midstream, Chemicals, Refining, Marketing and Specialties. The stock currently has a dividend yield of 2.35%. The company has a P/E ratio of 16.4. Currently, there are 8 analysts who rate Phillips 66 a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PSX - FREE

TheStreet Quant Ratings rates Phillips 66 as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Phillips 66 Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

HCA Holdings (HCA) - FREE Research Report

Riley Wayne Joseph, who is Director at HCA Holdings, sold 10,000 shares at $52.00 on May 8, 2014. Following this transaction, the Director owned 6,749 shares meaning that the stake was reduced by 59.71% with the 10,000-share transaction.

The shares most recently traded at $51.25, down $0.75, or 1.46% since the insider transaction. Historical insider transactions for HCA Holdings go as follows:

  • 4-Week # shares bought: 14,356
  • 4-Week # shares sold: 21,000
  • 12-Week # shares bought: 14,356
  • 12-Week # shares sold: 21,000
  • 24-Week # shares bought: 14,356
  • 24-Week # shares sold: 21,000

The average volume for HCA Holdings has been 2.8 million shares per day over the past 30 days. HCA Holdings has a market cap of $22.9 billion and is part of the health care sector and health services industry. Shares are up 7.27% year-to-date as of the close of trading on Thursday.

HCA Holdings, Inc., through its subsidiaries, provides health care services. The company has a P/E ratio of 14.4. Currently, there are 15 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCA - FREE

TheStreet Quant Ratings rates HCA Holdings as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and increase in net income. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full HCA Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists